Effect of TCV-309, a Novel Platelet Activating Factor Antagonist, on Hemodynamics in Dogs With Endotoxin-Induced Shock.

Journal of Veterinary Medical Science - Japan
doi 10.1292/jvms.57.385
Full Text
Abstract

Available in full text

Categories
Veterinary
Date
Authors
Publisher

Japanese Society of Veterinary Science

Related search

P-Selectin and Platelet-Activating Factor Mediate Initial Endotoxin- Induced Neutropenia

Journal of Experimental Medicine
MedicineAllergyImmunology
1994English

The Involvement of Platelet Activating Factor in Endotoxin-Induced Pulmonary Platelet Recruitment in the Guinea-Pig

British Journal of Pharmacology
Pharmacology
1987English

Cardiovascular and Renal Action of Platelet-Activating Factor in Anesthetized Dogs

Hypertension
Internal Medicine
1984English

Characterization of the Physicochemical Properties of Micelles of the Novel Platelet Activating Factor Receptor Antagonist, E5880.

membrane
2003English

Effects of Platelet-Activating Factor Receptor Antagonist (PAFRA) on Selected Inflammatory and Biochemical Parameters in Lipopolysaccharide-Induced Rat Endotoxemia Model

Kafkas Universitesi Veteriner Fakultesi Dergisi
Veterinary
2013English

LAU-0901, a Novel Platelet-Activating Factor Receptor Antagonist, Confers Enduring Neuroprotection in Experimental Focal Cerebral Ischemia in the Rat

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2009English

Studies of the Effect of a Platelet-Activating Factor Antagonist, CL 184,005, in Animal Models of Gram-Negative Bacterial Sepsis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

ENDOTOXIN EVOKES INTESTINAL PRODUCTION OF TUMOR NECROSIS FACTOR Α.• 309

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Platelet Activating Factor Revisited

Thorax
PulmonaryRespiratory Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy